![Henrik Kjaer Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henrik Kjaer Hansen
Directeur/Membre du Conseil chez
WCG CLINICAL, INC.
Profil
Henrik Kjaer Hansen is currently Director at Sonion A since 2022.
Mr. Hansen is Independent Director at WCG Clinical, Inc. since 2020.
Mr. Hansen is Senior Partner at Novo Principal Investments since 2017.
Mr. Hansen is Senior Partner at Novo Holdings A since 2017.
Former positions include Independent Director at Orexo AB from 2018 to 2023, Director at Xellia Pharmaceuticals AS, and Senior Vice President at Moelis & Company UK LLP.
Education includes undergraduate and graduate degrees from Copenhagen Business School.
Postes actifs de Henrik Kjaer Hansen
| Sociétés | Poste | Début |
|---|---|---|
| WCG CLINICAL, INC. | Directeur/Membre du Conseil | 01/01/2020 |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Directeur en chef des Investissements | 01/12/2017 |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Private Equity Investor | 01/01/2017 |
Sonion A/S
 Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Directeur/Membre du Conseil | 10/05/2022 |
Anciens postes connus de Henrik Kjaer Hansen
| Sociétés | Poste | Fin |
|---|---|---|
| OREXO AB | Directeur/Membre du Conseil | 27/10/2023 |
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs | Directeur/Membre du Conseil | - |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Henrik Kjaer Hansen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs | Health Technology |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Health Technology |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Finance |
Moelis & Co. (UK) LLP
Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
WCG Clinical, Inc.
 WCG Clinical, Inc. BiotechnologyHealth Technology Provides clinical research services | Health Technology |
